Compare

Advanced Biomed Inc. vs Aclarion, Inc. vs Renalytix plc vs First Choice Healthcare Solutions, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearAdvanced Biomed Inc.
ADVBRevenue covers only part of its income (partial revenue)
Aclarion, Inc.
ACON
Renalytix plc
RNLXYLast annual report: year ended 2024-06-30
First Choice Healthcare Solutions, Inc.
FCHS
Year ended2026-06-302025-12-312024-06-302025-12-31
Revenuen/a$75.7K$2.29Mn/a
Revenue growth (YoY)n/a+65.6%-32.7%n/a
Gross marginn/a9.0%6.8%n/a
Operating marginn/an/mn/mn/a
Net marginn/an/mn/mn/a
Net income$6.68M-$7.23M-$33.46M-$6.96M
EPS (Diluted)$5.33-$13.61-$0.31-$0.21
Operating cash flow-$1.95M-$7.16M-$30.11M-$549.0K
Free cash flown/a-$7.19Mn/an/a
Cash & equivalentsn/a$12.02M$4.68M$5.9K
Total assets$13.75M$13.67M$7.97M$4.05M
Total liabilities$1.47M$837.3K$15.83M$43.58M
Shareholders' equity$12.28M$12.84M-$7.85M-$39.53M
Return on year-end equity54.4%-56.4%n/an/a
Shares outstanding1.65M854.4K154.37M32.96M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearAdvanced Biomed Inc.Aclarion, Inc.Renalytix plcFirst Choice Healthcare Solutions, Inc.
Latestn/a$75.7K
Ended 2025-12-31
$2.29M
Ended 2024-06-30
$1.05M
Ended 2013-12-31
1 year earliern/a$45.7K
Ended 2024-12-31
$3.40M
Ended 2023-06-30
$1.16M
Ended 2012-12-31
2 years earliern/a$75.4K
Ended 2023-12-31
$2.97M
Ended 2022-06-30
$1.30M
Ended 2011-12-31
3 years earliern/a$60.4K
Ended 2022-12-31
$1.49M
Ended 2021-06-30
$1.26M
Ended 2010-12-31
4 years earliern/a$60.3K
Ended 2021-12-31
$0
Ended 2020-06-30
n/a